Trial Profile
A Phase I Study of Thrombopoietin (rhTPO) Plus G-CSF in Children Receiving Ifosfamide, Carboplatin, and Etoposide (I.C.E.) Chemotherapy for Recurrent or Refractory Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Thrombopoietin (Primary) ; Carboplatin; Etoposide; Ifosfamide
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 09 Jun 2015 New trial record